Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspar for Depressive Symptoms in Anxiety Disorder
NCT01546896Phase 4Withdrawn
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buspirone in generalized anxiety disorder (GAD), sponsored by Seoul National University Hospital. Planned start Mar 2012; status: withdrawn.
02
Drugs
buspirone
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT01546896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01546896.